"Failure to diagnose/delayed diagnosis/misdiagnosis is a much larger problem in POTS, and we have the data to back that up. Where is your data that over-diagnosis/misdiagnosis/self-diagnosis is happening at scale?"
Isn’t Gaffney’s point the entire point of this thread, so most of us would tend to agree with him in this case? Must we keep reiterating what’s been said over the last 18 pages..?
(Edit to remove comment about dysautonomia international)
"Over-diagnosis / misdiagnosis / self-diagnosis of EDS, MCAS, POTS, & Lyme is a real problem, and it would appear that there is little appetite by medical professionals to discuss this issue publicly."
Seems to me that once a medical professional throws tick-borne diseases like Lyme into a disease mix, we veer away from medicine and more into politics. It's been my experience that a large majority of clinicians and researchers have no real clue - they frequently merely mouth sound bites they heard from some other place.
It seems that they more or less are, but that also implies that hEDS is not a form of EDS (not the hypermobile subset of EDS).
The problem is then that HSD includes symptoms as a defining feature - so that it is not simply having different connective tissue. This makes it unworkable as a 'disease' category. The evidence for hypermobility per se being linked to fatigue or even generalised pain is pretty much zero. And it does not make much sense to call a spectrum a disoder. It will be a whole range of 'disorders' and so there will be be no consistent biomarkers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.